Susquehanna International Group’s Annovis Bio ANVS Stock Holding History

Susquehanna International Group’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$487K	Sell	218,336 -84,951	-28%	-$233K	﹤0.01%	9740
2025 Q4	$1.05M	Buy	303,287 +84,866	+39%	+$255K	﹤0.01%	7073
2025 Q3	$452K	Buy	218,421 +53,863	+33%	+$135K	﹤0.01%	9191
2025 Q2	$357K	Buy	164,558 +36,853	+29%	+$72.7K	﹤0.01%	9951
2025 Q1	$192K	Buy	127,705 +72,393	+131%	+$222K	﹤0.01%	10978
2024 Q4	$278K	Buy	55,312 +23,792	+75%	+$172K	﹤0.01%	9998
2024 Q3	$254K	Buy	+31,520	New	+$295K	﹤0.01%	9970
2024 Q2	–	Sell	-72,602	Closed	-$588K	–	11969
2024 Q1	$864K	Buy	72,602 +56,830	+360%	+$620K	﹤0.01%	7238
2023 Q4	$295K	Buy	+15,772	New	+$140K	﹤0.01%	9882
2023 Q2	–	Sell	-13,800	Closed	-$213K	–	11996
2023 Q1	$213K	Buy	+13,800	New	+$223K	﹤0.01%	10467

Other funds holding ANVS

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group's ANVS Position: Q1 2026 in Review

Susquehanna International Group reduced its Annovis Bio (ANVS) stake by 28% in Q1 2026, selling an estimated $233K and leaving 218,336 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #9740.

Susquehanna International Group first reported a position in ANVS in Q1 2023 and has held it in 10 quarters since. The position peaked at $1.05M in Q4 2025. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

Susquehanna International Group held 218,336 shares of Annovis Bio worth $487K as of Q1 2026.
Susquehanna International Group sold 84,951 Annovis Bio shares in Q1 2026, an estimated $233K.
Annovis Bio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9740 holding.
Susquehanna International Group first reported a position in Annovis Bio in Q1 2023 and has held it in 10 quarters since.
Susquehanna International Group's Annovis Bio position peaked at $1.05M in Q4 2025.
56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.